Search Results - Jon Rowland

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma by Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto S. Pappo, Wendy B. London, Marcio H. Malogolowkin

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma

    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma by Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, Laura C. Bowman, Marleta Reynolds, Milton J. Finegold, Brian Greffe, Jon Rowland, Kurt D. Newman, Richard B. Womer, Wendy B. London, Robert P. Castleberry

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome

    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome by Philippe M. Campeau, Jaeseung Kim, James T. Lu, Jeremy Schwartzentruber, Omar Abdul‐Rahman, Silke Schlaubitz, David M. Murdock, Ming-Ming Jiang, Edward J. Lammer, Gregory M. Enns, William J. Rhead, Jon Rowland, Stephen P. Robertson, Valérie Cormier‐Daire, Matthew N. Bainbridge, Xiang‐Jiao Yang, Marie‐Claude Gingras, Richard A. Gibbs, David S. Rosenblatt, Jacek Majewski, Brendan Lee

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: